These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19293764)

  • 1. New PET tracers for evaluation of solid tumor response to therapy.
    Larson SM; Schoder H
    Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):158-66. PubMed ID: 19293764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of conventional and novel PET tracers for imaging mesothelioma in nude mice with subcutaneous and intrapleural xenografts.
    Tsuji AB; Sogawa C; Sugyo A; Sudo H; Toyohara J; Koizumi M; Abe M; Hino O; Harada YN; Furukawa T; Suzuki K; Saga T
    Nucl Med Biol; 2009 May; 36(4):379-88. PubMed ID: 19423005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Evaluation of
    Antunes IF; Dost RJ; Hoving HD; van Waarde A; Dierckx RAJO; Samplonius DF; Helfrich W; Elsinga PH; de Vries EFJ; de Jong IJ
    J Nucl Med; 2021 Aug; 62(8):1140-1145. PubMed ID: 33517325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging.
    Katzenellenbogen JA
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32718075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET.
    Dunphy MP; Lewis JS
    J Nucl Med; 2009 May; 50 Suppl 1(Suppl 1):106S-21S. PubMed ID: 19380404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake.
    Monazzam A; Razifar P; Ide S; Rugaard Jensen M; Josephsson R; Blomqvist C; Langström B; Bergström M
    Nucl Med Biol; 2009 Apr; 36(3):335-42. PubMed ID: 19324279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel methods and tracers for breast cancer imaging.
    Linden HM; Dehdashti F
    Semin Nucl Med; 2013 Jul; 43(4):324-9. PubMed ID: 23725994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging of breast cancer.
    Oude Munnink TH; Nagengast WB; Brouwers AH; Schröder CP; Hospers GA; Lub-de Hooge MN; van der Wall E; van Diest PJ; de Vries EG
    Breast; 2009 Oct; 18 Suppl 3():S66-73. PubMed ID: 19914546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer.
    Larson SM; Morris M; Gunther I; Beattie B; Humm JL; Akhurst TA; Finn RD; Erdi Y; Pentlow K; Dyke J; Squire O; Bornmann W; McCarthy T; Welch M; Scher H
    J Nucl Med; 2004 Mar; 45(3):366-73. PubMed ID: 15001675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid imaging by SPECT/CT and PET/CT: proven outcomes in cancer imaging.
    Bockisch A; Freudenberg LS; Schmidt D; Kuwert T
    Semin Nucl Med; 2009 Jul; 39(4):276-89. PubMed ID: 19497404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer: role of SPECT and PET in imaging bone metastases.
    Beheshti M; Langsteger W; Fogelman I
    Semin Nucl Med; 2009 Nov; 39(6):396-407. PubMed ID: 19801219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation.
    Barwick T; Bencherif B; Mountz JM; Avril N
    Nucl Med Commun; 2009 Dec; 30(12):908-17. PubMed ID: 19794320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.
    Mortimer JE; Dehdashti F; Siegel BA; Katzenellenbogen JA; Fracasso P; Welch MJ
    Clin Cancer Res; 1996 Jun; 2(6):933-9. PubMed ID: 9816253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].
    Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X
    Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of O-[(18)F]fluoromethyl-D-tyrosine as a radiotracer for tumor imaging with positron emission tomography.
    Urakami T; Sakai K; Asai T; Fukumoto D; Tsukada H; Oku N
    Nucl Med Biol; 2009 Apr; 36(3):295-303. PubMed ID: 19324275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using dual-tracer PET to predict the biologic behavior of human colorectal cancer.
    Wang H; Zhang J; Tian J; Qu B; Li T; Chen Y; Liu J; Wang S
    J Nucl Med; 2009 Nov; 50(11):1857-64. PubMed ID: 19837754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer.
    Been LB; Hoekstra HJ; Suurmeijer AJ; Jager PL; van der Laan BF; Elsinga PH
    Oral Oncol; 2009 Dec; 45(12):e211-5. PubMed ID: 19692292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of radiolabelled anticancer drugs for positron emission tomography.
    Hutchinson OC; Collingridge DR; Barthel H; Price PM; Aboagye EO
    Curr Pharm Des; 2003; 9(11):931-44. PubMed ID: 12678876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic PET tracers beyond [(18)F]FDG and the novel quantitative approaches in PET imaging.
    Kumar R; Dhanpathi H; Basu S; Rubello D; Fanti S; Alavi A
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):50-65. PubMed ID: 18235421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular imaging (PET) of brain tumors.
    Basu S; Alavi A
    Neuroimaging Clin N Am; 2009 Nov; 19(4):625-46. PubMed ID: 19959009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.